Kasi ni njani uyo wangakoleka na kansa ya prostate?
Kansa ya prostate yikukoma comene ŵanalume, ndipo para munthu wakukura, ngozi yikukwera.
Kanandi ŵanthu awo ŵakusangika na nthenda iyi mbalara vyaka 65.
Vinyake ivyo vingapangiska munthu kuŵa na kansa ya prostate ni ivi:
1. Unandi wa vilimika: Para munthu wakukura, wangakoleka na kansa ya prostate, comenecomene ŵanalume awo ŵafika vyaka 65.
2. Mbiri ya mbumba: Ŵanalume awo ŵali na kansa ya mu ciŵaro ca munthumbo, comenecomene ŵadada panji ŵadumbu ŵawo, nawo ŵangakoleka na kansa iyi.
3. Mtundu: Ŵanalume ŵa mtundu wa African American ndiwo ŵakusuzgika comene na kansa ya prostate ndipo ŵakwamba kupokera matenda agha ŵacoko ndiposo para ŵamba waka.
4. Vinthu ivyo munthu wali kuhara: Vinthu vinyake ivyo munthu wali kuhara, nga ni majini gha BRCA1 na BRCA2, vingapangiska kuti waŵe na kansa ya prostate.
5. Vyakurya: Para munthu wakurya nyama zinandi na mkaka, wangakoleka na kansa ya prostate, kweni para wakurya vipasi na mphangwe wangakoleka yayi.
6. Kututuŵa: Para munthu ngwakujumphizga panji ngwakujumphizga comene wangakoleka na kansa ya prostate, kweniso kansa iyi yingaŵa yikuru comene.
7. Umoyo: Vinthu vinyake ivyo munthu wakucita, nga nkhukhweŵa hona na kutondeka kuthuta, vingapangiska kuti waŵe na kansa ya prostate.
Nangauli vinthu ivi vingapangiska kuti munthu wasuzgike na kansa ya prostate, kweni ni wose yayi awo ŵangakoleka na kansa iyi.
Para nyengo zose mukuyezgeka na kuphalira dokotala ivyo mukwenjerwa navyo, vingamovwirani kuti mwambe kumanya makora kansa ya prostate.
Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y: Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urol J. 2020, 17 (1): 42-49.
Advanced prostate cancer gets a new foe. Johns Hopkins Med Lett Health After 50. 2013, 25 (7): 8.
Vera Badillo FE: Metastatic prostate cancer gets into the biomarker era. Can Urol Assoc J. 2022, 16 (10): 333.
Gerard MJ, Frank-Stromborg M: Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications. Oncol Nurs Forum. 1998, 25 (9): 1561-9.
McDowell ME, Occhipinti S, Chambers SK: The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior. Health Psychol. 2013, 32 (11): 1158-69.
Razzaghi MR, Mazloomfard MM, Malekian S, Razzaghi Z: Association of macrophage inhibitory factor -173 gene polymorphism with biological behavior of prostate cancer. Urol J. 2019, 16 (1): 32-36.
['Kujivikilira: vya cipatala']
['Webusayiti iyi yili na cilato ca kusambizga waka ŵanthu, kuti njakupeleka ulongozgi wa vyacipatala yayi.']
['Manyani kuti makina agho ghakuzgora mafumbo agha ghakutondeka kulongosora makora vinthu nga ni unandi wa ŵanthu awo ŵali na nthenda yinyake.']
['Nyengo zose mukwenera kufumba dankha dokotala panji munthu munyake wakumanya vya munkhwala uyo wangamovwirani pa suzgo linu. Lekani kuzerezga ulongozgi wa dokotala panji kuchedwa kupenja ulongozgi uwu chifukwa cha ivyo mwaŵazga pa webusayiti iyi.']
['Copyright: Copyright']
['The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) imapereka mwayi kwa eni ake omwe amakhulupirira kuti zomwe zikuwoneka pa intaneti zikuphwanya ufulu wawo pansi pa malamulo a US copyright. ']
['Para mwalemba kalata, mukwenera kutuma pa adiresi ya e-mail (wonani pa "Contact").']
['Dango la DMCA likukhumba kuti para mwalemba kuti munthu munyake wananga vinthu ivyo muli navyo, mulembepo vinthu ivi: (1) ivyo vyalembeka, (2) ivyo vyalembeka, na ivyo vingatovwira kusanga ivyo vyalembeka, (3) umo tingamumanyira, na adiresi yake, nambara yake ya foni, na adiresi yake ya imelo, (4) usange mukugomezga kuti ivyo mwalemba ni vyambura kuzomerezgeka na mweneko wa vinthu, panji na munthu uyo wakumugwiliskira ntchito, panji dango lililose.']
['(5) mukalemba chikalata chakuyowoya kuti ivyo mwalemba ni vyaunenesko kweniso kuti muli na mazaza ghakuvikilira wanangwa uwo ŵanthu ŵakuti wanangika.']
['Ndipo (6) munthu uyo wali na wanangwa wa kulemba panji munthu uyo wali na mazaza ghakuchitira vinthu vinyake mu zina la mwenecho wa wanangwa uwu. ']
['Chonde titumizireni imelo ndi funso / lingaliro lililonse.']
Who gets prostate cancer?
Prostate cancer is a disease that primarily affects men, with the risk increasing with age.
It is most commonly diagnosed in men over the age of 65.
Some factors that may increase the risk of developing prostate cancer include:
1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.
2. Family history: Men with a family history of prostate cancer, particularly a father or brother with the disease, have a higher risk of developing prostate cancer themselves.
3. Race: African American men have a higher risk of developing prostate cancer and are more likely to be diagnosed at a younger age and with more aggressive forms of the disease.
4. Genetics: Certain inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, may increase the risk of developing prostate cancer.
5. Diet: A diet high in red meat and high-fat dairy products may increase the risk of prostate cancer, while a diet rich in fruits and vegetables may decrease the risk.
6. Obesity: Being overweight or obese may increase the risk of developing prostate cancer, as well as the likelihood of the cancer being more aggressive.
7. Lifestyle factors: Certain lifestyle factors, such as smoking and lack of physical activity, may increase the risk of developing prostate cancer.
It is important to note that while these factors may increase the risk of developing prostate cancer, not all men with these risk factors will develop the disease, and some men without any known risk factors may still be diagnosed with prostate cancer.
Regular screening and discussing any concerns with a healthcare provider can help to detect prostate cancer early, when it is most treatable.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
